Jazz Pharmaceuticals Public Limited Company (JAZZ)

120.26
NASDAQ
Prev Close 122.70
Day Low/High 119.64 / 124.42
52 Wk Low/High 117.64 / 189.00
Exchange NASDAQ
Shares Outstanding 61.47B
Market Cap 7.54B
P/E Ratio 53.37
Div & Yield N.A. (N.A)
Trades Can Still Work When Things Stink

Trades Can Still Work When Things Stink

There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.

Biotech Has Momentum

Biotech Has Momentum

Takeover news has the sector buzzing this morning.

Searching for a Pulse

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

The Day Ahead: Futures Point Higher

The Day Ahead: Futures Point Higher

Anticipation of a positive jobs report shows Wall Street edging higher in the early going.

Our September Report Card

Our September Report Card

We had great trades on the euro and the SPX, but we had some bad ones in FXF, SI and JAZZ.

Biotech Is Booming

Biotech Is Booming

Despite the solid performance so far this year, there's still time to get on board and ride the profit train.

S&P 500 on the Edge of a Breakout

S&P 500 on the Edge of a Breakout

If the market likes what it hears from the Fed, we could close above the important 1,219 level.

Chasing Big-Caps

Anticipation of the Fed announcement is likely to keep bids in place and keep the selling from gaining momentum.

Jazz Pharmaceuticals Is Swinging

Jazz Pharmaceuticals Is Swinging

Its chart shows that buyers are becoming more aggressive than sellers.

Shifting to Defense

Although the short side has been challenging, it makes more sense to lean that way.

Two Pharmas Offer High Potential

Two Pharmas Offer High Potential

The sector is seeing strong revenue, and Jazz and Amarin have the charts to match.

A Bounce Opportunity?

With volatility this high, play tight to avoid a whipsaw if a bounce comes.

Look for the Silver Lining

This currently horrible action will eventually lead to some very good opportunities.

The Day Ahead: Debt Deal Finally Reached

Investors cheered the U.S. debt agreement that Congress will vote on today.